1. Brainware University Digital Repository
  2. Serial Abstracting Service
  3. Journal & Magazine Article Abstracts
  4. Indian Journal of Chemistry
  5. Vol. 64 No. 7, 2025
Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5158
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVicky Lone-
dc.date.accessioned2026-06-05T13:01:10Z-
dc.date.available2026-06-05T13:01:10Z-
dc.date.issued2026-06-05-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5158-
dc.descriptionVol. 64, No. 7, p 730en_US
dc.language.isoenen_US
dc.subjectRepurposingen_US
dc.subjectAntimalarialen_US
dc.subjectMeflooquineen_US
dc.subjectDockingen_US
dc.subjectDynamic simulationen_US
dc.subjectAnticanceren_US
dc.titleRepurposing FDA approved antimalarial drugs: Mefloquine as a promising multitargeted therapeutic for non-small cell lung canceren_US
dc.typeOtheren_US
Appears in Collections:Vol. 64 No. 7, 2025

Files in This Item:
File Description SizeFormat 
1.pdfVol. 64, No. 7, p 730128.08 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.